The collaboration applies Concerto’s full stack data generation and AI platform to Sacco System’s microbial collections
CAMBRIDGE, Mass., Jan. 29, 2026 /PRNewswire/ — Concerto Biosciences®, the microbial ecology company, today announced that it has signed a development and commercialization agreement with Sacco System, a global biotechnology company specializing in the research, development and production of natural and innovative biotechnological solutions for the food, nutraceutical, pharmaceutical, and agro-veterinary industries, to advance next-generation microbial ingredient discovery.